Academic Journal

Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.

التفاصيل البيبلوغرافية
العنوان: Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
المؤلفون: Amatya, Vishwa J, Kushitani, Kei, Kambara, Takahiro, Suzuki, Rui, Takeshima, Yukio, Kai, Yuichiro, Tsutani, Yasuhiro, Miyata, Yoshihiro, Okada, Morihito
المصدر: Histopathology; Mar2019, Vol. 74 Issue 4, p545-554, 10p, 2 Color Photographs, 4 Charts, 1 Graph
مصطلحات موضوعية: DIAGNOSIS, MESOTHELIOMA, ADENOCARCINOMA, IMMUNOHISTOCHEMISTRY, ANTIGENS
مستخلص: Aims: The process of differential diagnosis between epithelioid mesothelioma and lung adenocarcinoma has been progressing; however, there are no absolute immunohistochemical markers with which to definitively diagnose epithelioid mesothelioma. The aim of this study was to search for a novel negative marker of epithelioid mesothelioma. Methods and results: We immunohistochemically studied the applicability of mucin 21 (MUC21), which was identified in our previous study, as a novel, negative diagnostic marker for epithelioid mesothelioma. Seventy epithelioid mesotheliomas and 70 lung adenocarcinomas were investigated for the expression of MUC21, along with other previously reported markers, by the use of immunohistochemistry. MUC21 was expressed in only two of the 70 (3%) epithelioid mesotheliomas, as compared with 67 of the 70 (96%) lung adenocarcinomas. The sensitivity, specificity and accuracy of negative MUC21 expression for differentiating epithelioid mesothelioma from lung adenocarcinoma were 97%, 96%, and 96%, respectively; these are similar to those of carcinoembryonic antigen and claudin‐4, and better than those of thyroid transcription factor‐1, napsin‐A, and mucin 4. Conclusion: MUC21 could be used as an additional, novel, negative immunohistochemical marker to differentiate mesothelioma from lung adenocarcinoma. [ABSTRACT FROM AUTHOR]
Copyright of Histopathology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03090167
DOI:10.1111/his.13775